Early Oral Tongue Squamous Cell Carcinoma
Jessica H. Maxwell(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Bernhard G. Weiss(University of Göttingen), Chi Lai, Lester D.�R. Thompson(Woodland Hills Medical Center), Margaret Brandwein‐Gensler(University of Alabama at Birmingham), Arpan V. Prabhu(Indiana University), Umamaheswar Duvvuri(City University of New York), Raja R. Seethala(University of Pittsburgh), Bibianna Purgina(Ottawa Hospital), William R. Carroll(University of Alabama at Birmingham), Robert L. Ferris(University of Pittsburgh), Seungwon Kim(UPMC Hillman Cancer Center), Martin Canis(LMU Klinikum), Jonas T. Johnson(University of Pittsburgh), Yongli Shuai(UPMC Hillman Cancer Center), Anthony B. Morlandt(University of Alabama at Birmingham)
Cited by 138
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688